EUVIMEDEUVIMED entdecken
Crossref

Photoresponsive Ferrocene‐ Augmented Iridium Polypyridyl Complex as an Oxidase Mimic for Selective Glutathione Sensing: Implications for Cancer Diagnostics and Therapy

Diksha J Baruah, Ankumoni Saikia, Hiranmoy Barman, Prasenjit Manna, Biswajit Saha iD, Manash R Das

Small · 2025

DOI: 10.1002/smll.202501627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Diksha J Baruah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Materials Sciences Group, Coal, Energy and Materials Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, I…. Hauptthemen laut MEDLINE: Iridium, Ferrous Compounds, Glutathione, Neoplasms. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Life Sciences Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The enzyme‐mimic activity of a well‐defined structurally characterized organometallic complex, [Ir(ppy)₂(fcbpy)]PF₆( 1 ; ppy = 2‐phenylpyridine; fcbpy = 4‐ferrocenyl‐2,2′‐bipyridine), a bimetallic iridium‐polypyridyl complex is investigated under light irradiation for the first time. This complex exhibits an extended excited‐state lifetime of 592 ns due to bimetallic synergy, and possess oxidase‐mimic activity in the presence of light. Leveraging this light‐activated oxidase‐mimic activity, a simple colorimetric assay is developed that successfully differentiates cancerous cells from normal cells, based on elevated glutathione (GSH) levels. Moreover, in cell viability studies, treatment with 1.25 mg L −1 of [Ir(ppy)₂(fcbpy)]PF₆ resulted in only 32.25% viability in a cancer cell line (A549) compared to the untreated control, highlighting its potent anticancer potential. Importantly, noncancerous cells (BEAS‐2B) maintain ≈72% viability at up to 10 mg L −1 of catalyst concentration, indicating selective cytotoxicity toward cancer cells. This study establishes [Ir(ppy)₂(fcbpy)]PF₆ as a promising candidate for both diagnostic and therapeutic applications in cancer, introducing a novel class of organometallic complexes with significant potential in bioassay development and targeted cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IridiumFerrous CompoundsGlutathioneNeoplasmsOxidoreductasesPyridinesLightHumansMetallocenesCell SurvivalCell Line, TumorCoordination Complexes

Stichwörter der Autor:innen

cancerenzyme catalysisiridiumironphotocatalysis

Substanzen

IridiumFerrous CompoundsGlutathioneMetallocenesferroceneOxidoreductasesPyridinesCoordination Complexes

Autor:innen und Institutionen

  • Materials Sciences Group, Coal, Energy and Materials Sciences Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India.
  • Academy of Scientific and Innovative Research, Ghaziabad, 201002, India.
  • Centre for Infectious Diseases, Biological Sciences and Technology Division, CSIR-North East Institute of Science and Technology, Jorhat, Assam, 785006, India.

ORCID-Profile: Biswajit Saha

Förderung

  • Life Sciences Research Board

Zitieren

APA

Baruah, D. J., Saikia, A., Barman, H., Manna, P., Saha, B., & Das, M. R. (2025). Photoresponsive Ferrocene‐ Augmented Iridium Polypyridyl Complex as an Oxidase Mimic for Selective Glutathione Sensing: Implications for Cancer Diagnostics and Therapy. Small. https://doi.org/10.1002/smll.202501627

Vancouver

Baruah DJ, Saikia A, Barman H, Manna P, Saha B, Das MR. Photoresponsive Ferrocene‐ Augmented Iridium Polypyridyl Complex as an Oxidase Mimic for Selective Glutathione Sensing: Implications for Cancer Diagnostics and Therapy. Small. 2025. doi:10.1002/smll.202501627

BibTeX
@article{Baruah2025,
  author = {Baruah, Diksha J and Saikia, Ankumoni and Barman, Hiranmoy and Manna, Prasenjit and Saha, Biswajit and Das, Manash R},
  title = {Photoresponsive Ferrocene‐ Augmented Iridium Polypyridyl Complex as an Oxidase Mimic for Selective Glutathione Sensing: Implications for Cancer Diagnostics and Therapy},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202501627}
}
Kostenlos starten →